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abstract
HIV infection is associated with immune-compromised and rising in opportunistic infection (secondary infection). Therefore, the 
number of mortality caused by HIV/AIDS is increasing. The use of ARV and development of HIV/AIDS management are expected 
to suppress the progress of HIV infection into AIDS and, therefore, the mortality can be diminished, while in fact most of the patients 
eventually suffer from AIDS due to secondary infection that commonly causes death. There should be a management by analysing 
microorganisms that trigger secondary infection. The method of this study was observational descriptive with cross sectional design. 
HIV infected blood samples were using ELISA Antibody (IgG and IgM) and Polymerase Chain Reaction (PCR) on laboratory test. The 
result showed correlation between HIV/AIDS severity and the amount and types of secondary infection. The most common secondary 
infections were toxoplasm (96.77%), hepatitis C (22.58%), tuberculosis (19.35%), and hepatitis B (3.22%). Other less frequent secondary 
infections, which were quite difficult to diagnose and not commonly found in Indonesia, were West Nile Virus (25.81%), Japanese 
Encephalitis Virus (3.22%), and Enterovirus (3.22%). Due to MDGs (Millenium Development Goals) target and the results above, 
researchers are highly demanded to contribute in decreasing mortality related to AIDS through early detection of secondary infection, 
including type of infection which have not been commonly found in Indonesia, such as West Nile Virus and Nipah Virus. The discovery 
of secondary infection in this study was not enough to suppress the occurrence of infection in HIV/AIDS patients. Antimicrobes and good 
nutrition are required. Moreover, there should be either a primary or secondary prophylaxis to prevent secondary infection that raises 
the number of mortality and morbidity of HIV/AIDS patients. The result of this study was to meet the target of MDGs by establishing 
new policies in handling HIV/AIDS infections and have potential as model for policy control in HIV/AIDS.
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abstrak
Infeksi HIV berkaitan dengan immune-compromised dan peningkatan infeksi oportunis (infeksi sekunder). Oleh karena itu angka 
kematian yang disebabkan HIV/AIDS semakin meningkat. Penggunaan ARV dan pengembangan penatalaksanaan HIV/AIDS diharapkan 
dapat menekan perkembangan HIV menjadi AIDS. Oleh karena itu tingkat kematian pun dapat berkurang, meskipun pada kenyataannya 
mayoritas pasien pada akhirnya mengidap AIDS karena infeksi sekunder yang umumnya mengakibatkan kematian. Diperlukan adanya 
sebuah penatalaksanaan dengan menganalisa mikroorganisme yang memicu terjadinya infeksi sekunder. Metode yang digunakan pada 
kajian ini merupakan pengamatan deskriptif dengan desain bagi silang. Sampel darah yang terinfeksi HIV dilakukan uji laboratorium 
menggunakan antibodi ELISA (IgG dan IgM) serta Polymerase Chain Reaction (PCR). Hasil penelitian menunjukkan adanya korelasi 
antara tingkat keparahan HIV/AIDS dengan jumlah dan jenis infeksi sekunder. Infeksi sekunder yang paling umum terjadi ialah 
toksoplasma (96.77%), hepatitis C (22.58%), tuberkulosis (19.35%) dan hepatitis B (3.22%). Infeksi sekunder lainnya dengan frekuensi 
lebih rendah yang jarang ditemui di Indonesia saat ini adalah Virus West Nile  (25.81%), Virus Japanese Encephalitis  (3.22%) and 
Enterovirus (3.22%). Berdasarkan target Millenium Development Goals (MDG) dan hasil penelitian tersebut di atas, peneliti sangat 
84 Indonesian Journal of Tropical and Infectious Disease, Vol. 5. No. 4 January–April 2015: 83-89
dituntut untuk berkontribusi dalam menurunkan tingkat kematian yang berkaitan dengan AIDS melalui deteksi dini infeksi sekunder, 
termasuk jenis infeksi yang belum lazim ditemui di Indonesia seperti Virus West Nile  dan Virus Nipah . Penelitian infeksi sekunder dalam 
kajian ini belum cukup untuk menekan terjadinya infeksi pada pasien HIV/AIDS. Antimikroba dan gizi yang baik sangat diperlukan. 
Selain itu diperlukan adanya profilaksi baik primer maupun sekunder untuk mencegah infeki sekunder yang dapat meningkatkan angka 
kematian dan morbiditas pasien HIV/AIDS. Hasil dari kajian ini adalah untuk memenuhi target MDGs dengan mengadakan kebijakan 
baru dalam penanganan infeksi HIV/AIDS dan berpotensi sebagai model untuk kebijakan kontrol pada HIV/AIDS.
Kata kunci: Mikroorganisme, infeksi sekunder, HIV/AIDS, model, kebijakan kontrol
introduction
HIV infection is associated with decreased endurance 
and increased incidence of opportunistic infections 
that in a given period of time raises a set of disease 
called Acquired Immunodeficiency Syndrome (AIDS).1 
Human Immunodeficiency Virus (HIV) remains a global 
health problem, including in Indonesia. World Health 
Organization (WHO) reported that 2001 up to 58 million 
people worldwide have been infected with HIV, while in 
Indonesia until 2009 there were an estimated 186,000 HIV-
positive people. The death rate from HIV/AIDS infection 
is reported quite high. Until 2000 it was reported that there 
were 22 million deaths related to HIV/AIDS.2
Indonesia was ranked first in the transmission of new 
cases of HIV and AIDS in Asia. Data from the Ministry 
of Health said there were 15,372 new HIV cases and 3541 
new AIDS cases in January to September 2012. Majority 
of the patients were male in productive age. The highest 
transmission is through sexual contact, followed by needles 
and drug users, and it is reported that the number of patients 
is increasing sharply compared to ten years ago. Along with 
increased capacity for early detection, screening programs 
and increased public awareness of HIV disease, we will find 
more new cases. The area with the highest number of new 
cases is DKI Jakarta, followed by Papua and East Java.3
Currently, with the developing management of 
HIV/AIDS infection and increasingly widespread use of 
antiretroviral drugs, the progression of HIV infection to 
AIDS and death from AIDS should be reduced. In fact, most 
of the patients fell into AIDS as a result of the emergence 
of secondary infections (opportunistic infections) that 
often leads the patients to death.1 In the decline of immune 
status, especially when the CD4 cells less than 200 
cells/mL, a variety of microorganisms such as bacteria, 
viruses, protozoa and fungal infections also appear tend to 
be easy to grow and reproduce, causing secondary infections 
in the body of the people with HIV/AIDS.4 The lower the 
CD4 cell count, the more types of microorganisms involved 
in secondary infection of HIV/AIDS. Fungal infections can 
occur simultaneously with bacterial infections, viruses and 
protozoa.2,5 The main problem faced by people with HIV/
AIDS is an opportunistic infection caused by a secondary 
infection.6 The more advanced the severity of HIV/AIDS, 
the more increasing the potential incidence of secondary 
infections and death. Analysis of microorganisms triggering 
the secondary infection, as is often seen in people with 
HIV/AIDS and other viruses, is associated with CD4 count 
and viral load. Some secondary infections include CMV 
(Cytomegalovirus), Mycobacterium tuberculosis, West Nile 
virus, hepatitis B and C virus, and Candida sp.7,8 It was not 
clear whether any people with HIV/AIDS will be infected 
by all these microorganisms.
Patients with infections are often followed by clinical 
conditions, such as malnutrition and wasting syndrome, 
which also will result in a decrease in CD4 T lymphocytes 
count. The condition results in a decrease of T lymphocytes 
count in patients susceptible to the incidence of secondary 
infections (opportunistic infections), such as hepatitis C, 
hepatitis B, hepatitis C, CMV, toxoplasmosis, Japanese 
encephalitis, West Nile virus, Nipah virus, all of which 
can be detected with CD4 and HIV RNA viral load. In 
HIV patients with secondary infections the increase of HIV 
progression is taking place. Therefore, HIV management 
policies is including promotion, prevention of secondary 
and tertiary infections, and complete therapy in accordance 
with the MDGs 2014, which comprises the absence of 
HIV-related deaths, the absence of new infections and the 
absence of discrimination.
This study aims to analyze how far the correlation 
between HIV/AIDS severity with the involvement of 
the type and number of secondary infections. The results 
are expected to be a new policy on HIV/AIDS, thereby 
supporting the achievement of the MDG targets in the field 
of infectious diseases of HIV/AIDS is zero new infections, 
zero discrimination, and zero AIDS-related deaths. From 
the laboratory results can be seen how far the relationship 
between the severity of HIV/AIDS with the involvement 
of the type and number of secondary infections. Based 
on the analysis of microorganisms triggers the secondary 
infection, according MDGs (Millennium Development 
Goals) in the field of infectious diseases HIV/AIDS, the 
results of this study are expected to contribute in lowering 
AIDS deaths through early detection of secondary infection, 
including an infection that has not been commonly detected 
in Indonesia, West Nile Virus Infection and Nipah virus. 
The results of this study are also expected to be a new policy 
on HIV/AIDS, thus supporting the achievement of the MDG 
targets, and can generate a new reference in the information 
and health sciences in the form of a journal.
85Rahayu RP, et al.: Analysis on Secondary Infection-triggering Microorganisms in HIV/AIDS Patients
methods
This study was a descriptive observational using 
cross-sectional design. Blood samples were taken from 
HIV-infected patients in Hospital Universitas Airlangga 
(RSUA), and Infectious Disease Intermediate Care Unit 
(Unit Perawatan Intermediet Penyakit Infeksi, UPIPI) 
Dr Soetomo Hospital, then we conducted laboratory tests 
to determine secondary infections experienced by the 
patients. From the laboratory results, we could see how 
far the relationship between the severity of HIV/AIDS 
with the involvement of the type and number of secondary 
infections. 
The laboratory tests were carried out at the Institute 
of Tropical Diseases (ITD), Universitas Airlangga. The 
study was conducted for three months. The population in 
this study was HIV-positive patients who have received 
antiretroviral therapy, whereas the samples in this study 
were part of the whole object under study who met the 
inclusion criteria. Criteria for inclusion in this study were 
as follows: willingness to involve, HIV-positive, and has 
received antiretroviral therapy. To obtain accurate results, 
this research was conducted using Antibody (IgG and IgM) 
ELISA and PCR.
resuLts & discusion
The number of patients included in this study was 31 
patients. The mean age of patients in this study was 35.06 ± 
11.20 years, with the youngest two years old and the oldest 
54 years of age. The highest number of the patients in age 
group of 31–45 years was 22 patients (70.96%), the least in 
the age group of < 16 years was 2 patients (6.46%), whereas 
the age group of 16-30 years was 3 patients (9.67%), and 
46–60 years was 4 patients (12.91%) (Figure 1).
Figure 1. HIV patients distribution by age group.
Characteristics of the subjects by sex showed that the 
males were 15 patients (48.38%) and females 16 patients 
(51.62%). A total of 26 (83.87%) patients had married and 
5 (16.13%) unmarried (Figure 2). Characteristics of study 
subjects based on tribes revealed Javanese of 27 (87.12%), 
Arabic 1 (3.22%), Chinese 1 (3.22%), Banjarese 1 (3.22%), 
and Tetungs 1 (3.22%).
Figure 2. Distribution of HIV patients by sex and marital 
status.
In this study, HIV/AIDS transmission through sex was 
21 patients (67.74%), through IDU (Intravenous Drug 
Users) was 8 (25.81%), and through vertical mother to child 
transmission (MTCT) was 2 patients (6.45%) (Figure 3).
Figure 3. Distribution of HIV by Route of Transmission.
 
A total of 29 (93.54%) patients had received antiretroviral 
drug therapy and 2 (6.46%), while the rest had not received 
(Figure 4).
Figure 4. Distribution of HIV patients by antiretroviral 
therapy.
According to the length of antiretroviral therapy, 
7 (24.14%) of the patients had received antiretroviral 
therapy for < 1 year, 11 (37.94%) patients for 1–3 years, 
6 (20.68%) patients for 3–5 years and 5 (17.24%) patients 
for > 5 years (Figure 5).
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Figure 5. Distribution of HIV patients by the length of 
antiretroviral therapy.
Based on HIV/AIDS clinical stage according to WHO 
in 2010, this study found that 13 (41.94%) of the patients 
were at stage I, 11 (35.48%) patients at stage II, 7 (22.58%) 
patients at stage III and there were no patients at stage IV 
(Figure 6).
Figure 6. Distribution of patients based on WHO’s clinical stage 
of HIV/AIDS.
In this study, most patients with undetected HIV viral 
load test results were 23 (74.19%) patients. Results of viral 
load < 4 ´ 102 copies/mL were in 2 (6.45%) patients and 
viral load > 4 ´  102 copies/mL were in 5 (16.12%) patients 
(Figure 7).
Figure 7. Patients distribution by HIV viral load.
Secondary Infection in Subjects Research
In this study we performed examination of secondary 
infections in people with HIV/AIDS. The results showed 
that 6 patients (19.35%) of the patients were with secondary 
infection of tuberculosis of 7 (22,58%) patients of the 
patients had secondary infection of hepatitis C, 1 (3.22%) 
of the patients had secondary infection of hepatitis B, 
30 (96.77%) with secondary infections Toxoplasma, 
8 (25.81%) with West Nile Virus, 1 (3.22%) patients 
with Japanese encephalitis virus, 2 (6.45%) patients with 
Enteroviruses, and 1 (3.22%) patients with secondary 
infections of dengue virus. There were no patients with 
secondary infection of cytomegalovirus (Figure 8).
Figure 8. Distribution of secondary infection in the subjects.
Secondary Infection in the Subjects by HIV/AIDS Clinical 
Stage
In this study, we performed examination on secondary 
infections in people with HIV/AIDS. Based on the clinical 
stage according to the WHO in 2010 the secondary infections 
appeared on stage I was tuberculosis of 3 patients (23.07%), 
Hepatitis C of 4 patients (30.76%), West Nile Virus of 
2 patients (15.38%), and Toxoplasma of 12 patients (92.31%). 
In stage II the secondary infections were Tuberculosis of 
3 patients (27.27%), Hepatitis C of 1 patients (9.09%), 
Hepatitis B of 1 patients (9.09%), West Nile Virus of 
6 patients (54.55%), Japanese encephalitis virus of 1 patients 
(9.09%), enterovirus of 1 patients (9.09%), dengue virus of 
1 patients (9.09%) and Toxoplasma of 11 patients (100%). 
Whereas, stage II the secondary infections were Hepatitis 
C of 2 patients (28.57%), enterovirus of 1 patients (14.28%) 
and Toxoplasma of 7 patients (100%).7
Figure 9. Distribution of secondary infection by HIV/AIDS 
Clinical Stage.
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Secondary Infection in the Subjects by HIV Viral Load
We carried out examination of secondary infections 
in people with HIV/AIDS. Based on HIV viral load, 
the secondary infections in patients with HIV viral load 
< 4 ´  102 copies/mL was toxoplasma of 2 (100%). Patients 
with HIV viral load > 4 ´ 102 copies/mL the secondary 
infections were tuberculosis in 2 (40.0%), hepatitis 
C 2 (40.0 patients, West Nile Virus of 1 patients (20.0%), 
Japanese encephalitis virus of 1 patients (20.0%), and 
enterovirus by 1 patients (20.0%), and Toxoplasma of 4 
patients (80.0%). Whereas, in patients with undetectable 
HIV viral load, the secondary infections were tuberculosis 
in 4 (17.39%) patients, hepatitis C 5 (21.73%), hepatitis 
B 1 (4.34%), West Nile Virus 7 (30.43%), enterovirus 
1 (4.34%), Dengue virus 1 (4.34%) and toxoplasma in 3 
(100%) (Figure 10).
Figure 10. Distribution of secondary infection by HIV viral 
load.
Characteristics of the study population
In this study, the subjects were patients with HIV/
AIDS of 31 patients. The mean age of the patients was 
35.06 ± 11.20 years, with the youngest 2 years old and the 
oldest 54 years of age. The age distribution of the patients 
showed those of < 16 years were 6.46%, 16–30 years 
were 9.67%, 31–45 years were 70.96%, and aged 46–60 
years were 12.91%. The proportion of males was 48.38% 
and females 51.52%, mostly (83.87%) were married and 
16.13% unmarried. This figure showed that the incidence 
of HIV/AIDS infections is more common in reproductive 
age, which is along with the data from the Ministry of 
Health of Indonesia in 2011 that the highest percentage of 
HIV/AIDS was at the age of 20–29 years with a ratio of 
men and women 3:1.
Indonesia ranked first in the transmission of new HIV 
and AIDS cases in Asia. Data report of the Directorate 
General of PP & PL, the Ministry of Health, mentioned that 
there were 15,372 new cases and 3541 new cases of AIDS in 
January to September 2012. The majority of sufferers were 
of childbearing age and men. Highest transmission was 
through sexual contact followed through needles of drug 
users. The number increased significantly when compared 
to ten years ago, along with an increase in the ability of the 
government to detect, to carry out screening programs and 
increase public awareness of HIV disease, then there will 
be more new cases to be found. Areas with highest number 
of new cases are Jakarta, followed by Papua and East Java. 
Since 1999 a new phenomenon in HIV/AIDS dispersion 
occurred, that was the predisposition of transmission 
through blood contact, especially among Intravenous Drug 
Users (IDUs). Transmission in IDUs occurs rapidly due to 
the use of shared needles. In 2000 there was a significant 
increase in the spread of HIV pandemic among sex workers 
in Indonesia (Indonesian Ministry of Health, 2011). In this 
study, sexual transmission of HIV/AIDS was 67.74%, 
through IDU (Intravenous Drug Users) was 25.81%, and 
through mother-to-child vertical transmission or MTCT 
(Mother to Child Transmission) was 6.45%. This indicates 
that the highest incidence rates of HIV/AIDS transmission 
was through unhealthy sexual relationships.
The discovery of antiretroviral drugs (ARVs) in 1996 led 
to a revolution in the treatment of PLWHA (People Living 
with HIV and AIDS). Although antiretroviral therapy 
has not been able to cure the disease and the presence of 
major challenges in terms of side effects of drugs and the 
incidence of chronic resistance to antiretroviral drugs, such 
therapy can dramatically reduce mortality and morbidity, 
and improve the quality of life of people living with HIV. 
Currently HIV/AIDS has been accepted as a disease that 
can be controlled and no longer considered a dread disease.2 
In this study showen that antiretroviral therapy has been 
widely used in patients with HIV/AIDS in Indonesia, and 
with quite a number of study subjects who had received 
antiretroviral therapy for more than 5 years showed the 
role of ARVs in increasing the life expectancy of people 
with HIV/AIDS. 
The findings in this research indicated that the majority 
of the study subjects were at an early stage (stage I and II) 
of HIV/AIDS infection. Undetectable viral load results 
indicated that the use of antiretroviral therapy in the majority 
of study subjects could control and suppress HIV/AIDS 
progress and improve the quality of life of the patients. This 
is in accordance with the policy on HIV/AIDS in Indonesia, 
which includes 4 pillars, all of which are aimed at bringing 
about a paradigm of zero new infection, zero AIDS-related 
death and zero discrimination:9,10 (1) prevention: includes 
prevention of HIV transmission through sexual behavior 
and syringe, prevention in prisons and detention centers, 
prevention of mother-to-child transmission (PMTCT), 
prevention of transmission among sex workers and others, 
(2) Maintenance and support treatment (PDP): includes 
the strengthening and development of health services, 
prevention and treatment of opportunistic infections, ARV 
treatment, as well as support and education, training people 
living with HIV. PDP program is primarily intended to 
reduce morbidity and hospitalization, mortality related to 
HIV-AIDS and improve the quality of life of people living 
with HIV, (3) Mitigation of the impact of psychosocial and 
economic support, (4) creation of a conducive environment 
(creating the enabling environment) which includes 
institutional strengthening and management, program 
management and policy alignment.
With growing HIV/AIDS management infection 
and increasingly widespread use of antiretroviral drugs, 
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progression of HIV infection to AIDS and death from 
AIDS should have been suppressed. In fact, most of the 
patients fell into the emergence of AIDS as a result of 
secondary infections that often lead to death. Declining CD4 
cell count to some extent (< 200 cells/mm3) will open up 
opportunities for a secondary infection. The more advanced 
severity of HIV/AIDS, the more increase the potential 
incidence of secondary infection and death.1 Based on 
Figure 8, there were no patients with secondary infection of 
cytomegalovirus. In this study, the encountered secondary 
infections were mostly Toxoplasma, as many as 96.77%. 
High toxoplasma infection in HIV/AIDS is related to the 
deterioration of the immune system.11,12,13 
The parasite Toxoplasma gondii can reactivate again 
when CD4 lymphocyte count decreases to below 100 
cells/mcl. The incidence of toxoplasma seroprevalence in 
a group of non-HIV individuals and groups of individuals 
with HIV/AIDS is almost the same, which is about 10–40%. 
In the United States, 67% of people with HIV/AIDS have 
positive Toxoplasma antibodies. However, the possibility 
of reactivation is 30% higher in people with HIV/AIDS.11 
Secondary infection of tuberculosis in this study was 
found to be 19.35%. This finding is in line with secondary 
tuberculosis infection data on HIV/AIDS. Tuberculosis 
is a secondary infection most often found in people with 
HIV and is the largest cause of morbidity and mortality 
in HIV infection in the world. More than 11 million HIV 
infections is accompanied with TB.14,15,16 Thirty percent of 
is the cause of death in people with HIV is TB.17 Data in 
UPIPI Dr. Soetomo Hospital showed that manifestations of 
AIDS due to secondary infection of pulmonary TB reaches 
25–83%.17
Hepatitis B and hepatitis C are blood-borne diseases, 
together with HIV transmission. Both are secondary 
infections commonly found in people living with HIV who 
are injecting drug users (IDUs). Coinfection of hepatitis 
C and HIV among injecting drug users were 40–90%, 
whereas coinfection of hepatitis B and HIV in sexual 
transmission was 77%.18 In this study, secondary infection 
of 3.22% with hepatitis B and hepatitis C was 22.58%. This 
is because the transmission of HIV infection in the study 
was largely through sexual transmission (67.74%) and 
through injecting drug use (IDU) (25.81%).
Another finding in this study was the secondary 
infection that is rare and often undiagnosed in Indonesia, 
such as Japanese encephalitis virus, West Nile virus 
(WNV), enterovirus, and dengue viruses.19 In this study, 
secondary infection of West Nile Virus was found to be 
25.81%, which is quite a high figure for a rare viral infection 
and rarely diagnosed in Indonesia. WNV infection is a 
viral infection that is transmitted through mosquito bites, 
self-limited with mild symptoms such as flu-like syndrome 
that can occur more severe in HIV co-infection with 
neurological manifestations such as meningoencephalitis. 
There has been no report on the epidemiological data of 
WNV and HIV coinfection rate. Only in the United States 
some cases of WNV and HIV co-infection was reported 
with manifestations of severe encephalitis.20
As WNV, Japanese encephalitis virus (JEV) is also a 
coinfection virus that can be found in HIV. Often found in 
Asian countries including Indonesia, JEV is a flavivirus 
transmitted by mosquito bite with severe neurological 
manifestations of encephalitis and high mortality rate up 
to 60%.21 In this study, a secondary infection of JEV was 
found to be 3.22%. Although the data on JEV findings 
is low, these findings need attention because of the 
limitations of the study that was only in Surabaya (which 
is a reference to Eastern Indonesia). Thus the molecular 
epidemiological studies are necessary to get the database 
on JEV infections that accompany HIV/AIDS so that the 
mortality rate of patients with HIV/AIDS can be prevented 
early. Enterovirus is a virus that is identified as one of 
the causes meningoencephalitis in patients with HIV. 
Neurological deficits often appear along with a decrease in 
CD4 cell counts. More common in children, enteroviruses 
are often associated with complaints of diarrhea in people 
with HIV.22
Dengue virus has been reported to coinfect with HIV. 
With the decline in immune status in HIV and high infection 
rates in dengue endemic areas, the incidence of co-infection 
becomes possible.23 There have been no reports of dengue 
and HIV coinfection rate, but in this study, the rate was 
found to be 3.22%. The findings of secondary infection in 
this study showed ARVs alone is not sufficient to reduce 
the incidence of secondary infection in HIV/AIDS, so that 
it requires antimicrobial therapy and adequate nutritional 
support. There should also be a primary or secondary 
prophylactic measures to combat secondary infections 
that can increase mortality and morbidity of patients with 
HIV/AIDS. Primary prophylaxis is given to prevent an 
infection that has never been suffered, while secondary 
prophylaxis is a treatment given to prevent the repetition 
of an infection which never been suffered before. For 
primary prophylaxis we can give cotrimoxazole tablets of 
960 mg/day single dose for 2 years, while for secondary 
prophylaxis the treatment was given in accordance with 
arising secondary infections. 
concLusion
Toxoplasma (96.77%) which is the most common 
secondary infection is higher than other infection. The 
benefits of this research to the patients is that they know 
the type and number of secondary infections associated 
with the severity of HIV/AIDS suffered, so they may 
immediately seek treatment in order to have better 
prognosis. By proving relationships between HIV/AIDS 
severity and the involvement of microorganisms in HIV/
AIDS secondary infection, we can take strategic policy to 
reduce the transmission rate of secondary infections and 
related deaths.
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